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Psoriasis is a common skin disorder of multifactorial origin. Genomewide scans for disease susceptibility have
repeatedly demonstrated the existence of a major locus, PSORS1 (psoriasis susceptibility 1), contained within the
major histocompatibility complex (MHC), on chromosome 6p21. Subsequent refinement studies have highlighted
linkage disequilibrium (LD) with psoriasis, along a 150-kb segment that includes at least three candidate genes
(encoding human leukocyte antigen–C [HLA-C], a-helix–coiled-coil–rod homologue, and corneodesmosin), each
of which has been shown to harbor disease-associated alleles. However, the boundaries of the minimal PSORS1
region remain poorly defined. Moreover, interpretations of allelic association with psoriasis are compounded by
limited insight of LD conservation within MHC class I interval. To address these issues, we have pursued a high-
resolution genetic characterization of the PSORS1 locus. We resequenced genomic segments along a 220-kb region
at chromosome 6p21 and identified a total of 119 high-frequency SNPs. Using 59 SNPs (18 coding and 41 noncoding
SNPs) whose position was representative of the overall marker distribution, we genotyped a data set of 171
independently ascertained parent–affected offspring trios. Family-based association analysis of this cohort high-
lighted two SNPs (n.7 and n.9) respectively lying 7 and 4 kb proximal to HLA-C. These markers generated highly
significant evidence of disease association ( ), several orders of magnitude greater than the observed sig-59P ! 10
nificance displayed by any other SNP that has previously been associated with disease susceptibility. This observation
was replicated in a Gujarati Indian case/control data set. Haplotype-based analysis detected overtransmission of a
cluster of chromosomes, which probably originated by ancestral mutation of a common disease-bearing haplotype.
The only markers exclusive to the overtransmitted chromosomes are SNPs n.7 and n.9, which define a 10-kb
PSORS1 core risk haplotype. These data demonstrate the power of SNP haplotype-based association analyses and
provide high-resolution dissection of genetic variation across the PSORS1 interval, the major susceptibility locus
for psoriasis.
Introduction
Psoriasis (MIM *177900) is a common, inflammatory
skin disorder of unknown etiology (Camp 1998). The
most prevalent form of the disease, chronic plaque pso-
riasis, is characterized by red scaly lesions that appear
predominantly on extensor surfaces and are due to ke-
ratinocyte hyperproliferation, inflammatory-cell dermal
infiltration, and new vessel formation (Barker 1991; Bos
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and De Rie 1999). Although rarely fatal, the disease is
debilitating through its significant impact on quality of
life (Nevitt and Hutchinson 1996). Approximately 3%
of the population in developed countries have psoriasis,
with health care costs exceeding $3 billion per year in
the United States alone (Sander et al. 1993).
Although environmental agents, including infection
and drug exposure, are risk factors in the development
of psoriasis, twin and family studies point to a strong
genetic component. The recurrence risk of psoriasis in
first-degree relatives of affected subjects is ∼10 times
greater than that seen in the general population (Lom-
holt 1963; Hellgren 1967). Associations with psoria-
sis—in particular, between psoriasis and the HLA-Cw6
antigen—have been reported in a wide range of ethnic
groups, supporting the presence of a susceptibility gene
or genes within the major histocompatibility complex
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(MHC) (Tiilikainen et al. 1980). More recently, linkage-
based genomewide scans have identified chromosomal
regions outside theMHC that harbor putative psoriasis-
susceptibility loci (for review, see Elder et al. 2001; Ca-
pon et al. 2002). However, the majority of these studies
generated highly significant evidence of linkage on chro-
mosome 6p21 (PSORS1), supporting its role as the ma-
jor susceptibility locus for psoriasis (Nair et al. 1997;
Trembath et al. 1997; Lee et al. 2000; Veal et al. 2001).
As an initial attempt to refine the PSORS1 genomic in-
terval, microsatellite maps of varying density have been
used as a framework for linkage disequilibrium (LD)–
based fine mapping (Balendran et al. 1999; Oka et al.
1999; Nair et al. 2000). Taken together, these studies
support a 150-kb minimal LD region, within the prox-
imal segment of the MHC class I region, as the most
likely location for PSORS1 (for review, see Capon et
al. 2002). This interval contains five known genes, three
predicted transcripts, and a number of ESTs (Oka et al.
1999). PSORS1 positional candidate genes have also
been analyzed, and significant disease associations have
been identified for the genes encoding human leukocyte
antigen–C (HLA-C [MIM *142840]), octamer-binding
transcription factor–3 (OTF3 [MIM *164177]), a-he-
lix–coiled-coil–rod homologue (HCR [MIM *605310]),
and corneodesmosin (CDSN [MIM *602593]) (Allen et
al. 1999; Mallon et al. 1999; Tazi Ahnini et al. 1999;
Asumalahti et al. 2000, 2002; Gonzalez et al. 2000). In
particular, significant associations have been detect-
ed for nonconservative coding polymorphisms within
HCR (e.g., HCR269; see Asumalahti et al. 2000) and
CDSN (e.g., CDSN1243; see Allen et al. 1999). How-
ever, data interpretations are compounded by a lack of
detail on the background pattern of LD both across the
region and between the associated alleles (Jenisch et al.
1999; Chia et al. 2001; O’Brien et al. 2001). The sto-
chastic nature of LD conservation is a major confound-
ing factor in the design of disease-association studies,
and the use of dense marker maps has been proposed
as a possible means to improve resolution (Weiss and
Terwilliger 2000; Cardon and Bell 2001).
SNPs—inherited, biallelic, 1-bp differences that are
present in the human genome at a density of 1–10 per
1,000 nt—can significantly improve resolution in ge-
netic studies (International SNP Map Working Group
2001). SNPs are more abundant throughout the ge-
nome and are less prone to mutation, as compared to
STRs (i.e., microsatellites) (International SNP Map
Working Group 2001).
In the present study, we have generated a high-density
SNP map of a large genomic segment that includes the
150-kb minimal PSORS1 region but extends to 35 kb
on either side of the interval boundaries. We have used
the reference sequence developed by the MHC Sequenc-
ing Consortium (1999), and we have undertaken system-
atic SNP discovery by direct sequencing of eight affected
individuals carrying PSORS1 risk haplotypes. By geno-
typing 59 SNPs, we have determined the allelic associ-
ations and fine structure of the haplotypes in the region.
Family-based association studies and haplotype analysis
highlight a 10-kb genomic segment, defined by two SNPs
that lie 7 and 4 kb proximal to HLA-C, as contributing
to psoriasis susceptibility at the PSORS1 locus.
Subjects and Methods
Subjects
A total of 171 previously described family-based trios
of European origin (Asumalahti et al. 2002), each in-
cluding an affected offspring and both parents, were
ascertained, through information obtained from spe-
cialist dermatology clinics, at St John’s Institute of Der-
matology, London, and from a network of collaborating
sites throughout England and Scotland (Balendran et al.
1999). One hundred forty-nine parent-offspring units
were derived from a family data set previously analyzed
by Veal et al. (2001), and a further 22 trios, with and
without a family history of psoriasis, were recruited for
the purpose of this study. All probands had severe and
extensive chronic plaque psoriasis, as assessed by two
experienced dermatologists (J.N.W.N.B. and D.B.), us-
ing established clinical criteria (Camp 1998). A further
cohort of case ( ) and control ( ) individ-np 77 np 77
uals of Gujarati Indian descent were ascertained as de-
scribed elsewhere (Asumalahti et al. 2002). All subjects
were genotyped for HLA-C. Analysis of LD conservation
was determined for an unaffected control population of
90 unrelated U.K.-based subjects of European origin.
For sequence analysis, we included eight psoriatic in-
dividuals with known microsatellite MHC haplotypes
from a cohort described by Balendran et al. (1999). The
ascertainment of subjects and the study were undertaken
after receipt of approval from the Guy’s and St Thomas’
hospitals ethics committee of King’s College, London.
SNP Identification
DNA from eight individuals who were known to
be heterozygous for microsatellite-defined, high-risk
PSORS1 haplotypes, was used to identify sequence
variants in the 220-kb target region (Balendran et al.
1999). To recognize SNPs and thereby assess patterns
of LD conservation, we also resequenced additional
genomic fragments across a 700-kb area that was
delimited by the tumor necrosis factor–b (TNFb) and
DDR genes.
PCR primers that amplify 2–2.5-kb fragments were
designed on the basis of the consensus MHC sequence,
which has been deposited in GenBank. PCRs were per-
formed in 96-well microtiter plates (Abgene) on MJ Re-
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search DNA Engine Tetrads with a 50-ml reaction vol-
ume that contained 50 ng DNA, 45 mM Tris HCl (pH
8.8), 11 mM NH4SO4, 4.5 mM MgCl2, 6.7 mM b-mer-
captoethanol, 4.4 mM EDTA (pH 8.0), 1 mM deoxyri-
bonucleoside triphosphates, 113 mg/ml BSA, 10 pmol
each primer, and 1 U Taq polymerase (Jeffreys et al.
1988). Amplified products were purified with the Multi-
Screen PCR system (Millipore), were sequenced using
Big Dye Terminators (Applied Biosystems), and were
electrophoresed through 5% LongRanger (FMC) poly-
acrylamide gels on an ABI 377 automated sequencer
(Applied Biosystems). Sequence runs were aligned using
ABI SeqEd 1.03, and SNPs were identified by visual in-
spection of chromatograms. Only SNPs presenting a mi-
nor-allele frequency 10.25 were genotyped. (For a de-
tailed description of the entire SNP and primer resource,
including position and nucleotide substitution, see tables
A1–A7, in appendix A, available online only.)
SNP Genotyping
Genomic DNA was extracted from whole blood as
described elsewhere (Trembath et al. 1997). DNAs were
plated out in family order in deep-well microtiter plates
(Abgene), each of which included control samples from
the eight individuals analyzed by resequencing. Plated
DNA samples were amplified using sequence-analysis
primers, and resultant products were blotted onto Hy-
bond N (Amersham).
For each SNP, a pair of allele-specific oligonucleotides
(ASOs) was synthesized. All probes were 18-mers, with
the SNP located 8 nt from the 5′ end. ASOs were end-
labeled to probe dot blots of the corresponding PCRprod-
ucts, as described by Jeffreys et al. (2000). In brief, 3 ng
ASOs/ml were hybridized to blots at 53C for 1 h, in a
buffer that contained 3 M tetramethylammonium chlo-
ride (TMAC), 0.6% SDS, 10 mM sodium phosphate (pH
6.8), 1 mM EDTA, 0.1% Ficoll 400, 0.1% polyvinylpyr-
rolidone, 0.1% BSA, 4 mg yeast RNA/ml, and 10 mg sin-
gle-stranded herring sperm DNA/ml. Filters were washed
in 3 M TMAC, 0.6% SDS, 10 mM sodium phosphate
(pH 6.8), and 1 mM EDTA at 56C for 20 min; were
rinsed in 3 # saline sodium citrate at room temperature;
and were autoradiographed. Alleles were assigned by di-
rect examination of autoradiographs compared for each
allele, and Genetics Analysis Suite 2.0 (Alan Young, Ox-
ford 1993–1995) was used to confirm Mendelian inher-
itance and to generate files for statistical analyses.
Statistical Analyses
Family-based association analysis was performed using
TRANSMIT 2.5 (Clayton 1999). This package tests for
association through the examination of transmission rates
for markers and multilocus haplotypes, under “phase
known” and “phase unknown” conditions. The tests
are based on a score vector, which is averaged over all
possible configurations of parental haplotypes and
transmissions, consistent with the observed data (Clay-
ton 1999). Excessive transmission of each haplotype is
assessed using an asymptomatic x2 test with 1 df. All
markers were analyzed independently. To compensate
for differences, reflecting allele frequency, in marker
informativity, we also performed a three-locus hap-
lotype analysis. The significance of this data set was
assessed by simulation (with a program written, by
C.D.V., in Visual Basic 6.0 [Microsoft]), generating
10,000 replicates of the data set with normal Men-
delian inheritance from the parental genotypes. Trans-
mission was assessed for each marker per replicate,
and the number of times that particular x2 values oc-
curred was noted and compared to expected frequency.
Full-length haplotypes and frequencies were also com-
puted using TRANSMIT. Because of computational lim-
itations, overlapping segments of 10–15 SNPs were first
determined. These were then pieced together, in succes-
sion, by the identification of unique SNPs in overlapping
regions, until full-length haplotypes were generated. A
subselection of markers that defined the haplotypes with
a frequency 11% were then analyzed with PHASE 1.0
(Stephens et al. 2001), to identify and confirm haplo-
types for each individual. This approach uses coalescent
theory to predict haplotypes in population data.
Analysis of LD conservation among controls was per-
formed using ad hoc software written, by Alec Jeffreys,
in True Basic 4.1. The program estimates maximum-
likelihood haplotype frequencies from the unphased dip-
loid genotype, assuming that all markers are in Hardy-
Weinberg equilibrium. On the basis of these haplotype
frequencies, the level of LD between each pair of SNPs
is assessed using the D′ measure of complete association
(Jeffreys et al. 2001). LD conservation was also calcu-
lated in the untransmitted chromosomes, as found by
PHASE and representing nondisease or control chro-
mosomes, using D′ values calculated by a simple pro-
gram written, by C.D.V., Visual Basic 6.0 (Microsoft).
Results
Resequencing and SNP Identification
within the PSORS1 Interval
A high-density SNP map was generated by the rese-
quencing of 83 PCR fragments (fig. 1) in each of eight
affected individuals who carried a high-risk PSORS1
haplotype, as described by Balendran et al. (1999). Se-
quence analysis identified 119 SNPs, with a minor-allele
frequency greater than the 25% arbitrary threshold
value. Of these, a subset of 59 SNPs (fig. 1)—including
all coding SNPs reported to show significant association
with psoriasis (see the “Introduction” section)—yielded
robust genotypes in 180% of the data set and provided
representative distribution for all resequenced segments.
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Figure 2 Patterns of LD conservation, as measured by analysis of 15 SNPs spanning 700 kb, at the boundary between MHC class I and
class III loci. D′ decay from HLA-C SNP 290 (dashed line) and from CDSN1243 (continuous line) is plotted against distance and location of
analyzed genes. The asterisk (*) and double asterisk (**) symbols denote the positions of HLA-C SNP 290 and of CDSN1243, respectively.
LD-Conservation Patterns
To reduce potential confounding effects from ascer-
tainment bias, we investigated LD-conservation pat-
terns in a sample ( ) of healthy, unrelated indi-np 90
viduals. Figure 2 shows the results from the analysis
of diploid LD between 15 SNP loci. LD appears to be
maintained between HLA-C and OTF3 ( ) but′D 1 0.8
sharply decreases in the region between OTF3 and
CDSN. We observed no evidence for LD between
HLA-C and MICA ( ).′D ! 0.2
This pattern of LD was also observed in the family
cohort with psoriasis, by using the population of paren-
tal untransmitted chromosomes, with a D′ value of 0.8
between SNPs n.15 (6 kb distal from HLA-C) and n.43
(within HCR). D′ was 0.15 for LD between SNPs n.15
and n.58 (within CDSN).
Association Studies
Figure 3a illustrates the results of single-marker trans-
mission/disequilibrium testing for the 59 SNPs genotyped
in the 171 parent–affected offspring trios. Significant as-
sociation with psoriasis was observed throughout the re-
sequenced regions, with a total of 26 SNPs generating x2
values 110.8 ( ). Two SNPs—n.7 and n.9, re-P ! .001
spectively lying 7 and 4 kb proximal to HLA-C—yielded
P values !109, exceeding by several orders of magnitude
the significance displayed by any other marker in the data
set. For SNPs distal to n.7 and n.9, 195% of loci dem-
onstrated a significant decrease in x2 values ( ).6P 1 10
Three-SNP haplotype analysis was also performed (fig.
3b). The pattern of association is maintained, with the
haplotypes that contained SNPs n.7 and n.9 generating
extreme P values ( ). In simulations of13Pp 7.93# 10
590,000 genotypes (10,000 replicates for each of the
59 SNP-based genotypes), no similar x2 values were ob-
served. To further characterize the pattern of haplotype
association centromeric to SNPs n.7 and n.9, we geno-
typed three additional coding sequence variants that are
found in MICA, the next non-HLA gene beyond HLA-
C. This revealed a sharp decrease in x2 values, indicating
that the peak of association is neither increased nor main-
tained beyond SNPs n.7 and n.9. Assessment of a further
cohort of case and control individuals of distinct ethnic
origin also yielded evidence that SNPs n.7 and n.9 exhibit
greater association than SNPs n.43 (HCR269) and n.58
(CDSN1243) (see table 1).
PSORS1 Haplotype Analysis
An extended haplotype analysis for the entire PSORS1
region is shown in figure 4. A total of 23 haplotypes, each
with a frequency 11%, were observed. Nine haplotypes
(haplotypes 15–23) were overtransmitted to affected off-
spring. All overtransmitted haplotypes exclusively in-
cluded SNPs n.7 and n.9. Only clusters D and E were
more frequent in the transmitted chromosomes—in the
case of cluster E, representing a fourfold excess (45%
in all transmitted chromosomes; 11% in all untrans-
mitted chromosomes). We compared the presence of
SNPs n.7 and n.9 with the previously genotyped pres-
ence of HLA-Cw6, in the affected offspring. Of the 120
subjects genotyped for each locus, 93 (77.5%) possessed
each of the risk alleles, 6 (5%) carried only SNPs n.7
and n.9, and 1 (0.83%) carried HLA-Cw6 alone; 20
(16.7%) of the affected probands harbored other alleles
at these loci.
Discussion
We have developed an SNP-based map of the PSORS1
susceptibility locus, with the specific aim of increasing
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Figure 3 Output of TRANSMIT family-based association analysis undertaken using all 171 parent–affected offspring trios. a, Results of
single-marker analysis. x2 values at each marker are plotted against distance and position of known genes. b, Results of three-marker analysis.
x2 values for consecutive haplotypes are plotted against distance and position of known genes.
the resolution of mapping data for the major genetic
discriminant for psoriasis. Interestingly, recent studies
have demonstrated that most genomic regions can be
decomposed into discrete blocks of low haplotype di-
versity that are separated by intervals corresponding to
historical recombination breakpoints. Crossover events
appear to be clustered between blocks, with little or no
exchange within blocks (Daly et al. 2001; Jeffreys et al.
2001). Hence, reliable fine mapping of complex traits
can be achieved by genotyping a limited number of SNPs
within a critical interval, provided that such markers are
representative of the region’s composition of LD blocks
(Daly et al. 2001; Rioux et al. 2001). Thus, in this study,
we did not seek to identify or genotype all SNPsmapping
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Table 1
Analysis of Associated in SNPs in the Gujarati Case/Control
Population
SNP
NO. (FREQUENCY) AMONG
Pa
Case Individuals Control Individuals
Allele 1 Allele 2 Allele 1 Allele 2
n.7 94 (60%) 62 (40%) 92 (75%) 30 (25%) .01
n.9 98 (60%) 66 (40%) 100 (75%) 34 (25%) .01
HCR269
(n.43) 110 (77%) 32 (23%) 132 (86%) 22 (14%) .09
CDSN1243
(n.58) 69 (48%) 73 (52%) 76 (44%) 78 (56%) .1
a By test.2x
to the target region; rather, we resequenced segments
(total length 60 kb) of the PSORS1 interval, to generate
an essential framework SNP map.
The most significant evidence for disease association
was observed for SNPs n.7 and n.9, with probability
values clearly exceeding any other markers studied, in-
cluding coding SNPs that identified variants that have
previously been implicated in psoriasis susceptibility
(Allen et al. 1999; Asumalahti et al. 2000). By way of
replication, these observations were supported in a case/
control study of an Indian cohort with psoriasis. SNPs
n.7 and n.9 lie in a noncoding region, respectively 7
and 4 kb centromeric to HLA-C. Although it is possible
that these SNPs are themselves disease-causing variants,
on the basis of the available data, we consider this to
be unlikely. In a three-marker association analysis at
these loci, we observed higher x2 values, compared to
those generated for a single-marker assessment. Such an
incremental change in significance is likely to indicate
that the strength of association between these SNPs and
disease is influenced substantially by marker informa-
tivity. We might expect this to be the case for any SNP
other than the disease-causing allele, whose informativ-
ity is, by definition, absolute (Martin et al. 2000). An
alternative explanation would require that SNPs n.7
and n.9 each be independent susceptibility alleles, yet
such a hypothesis would require both mutations to have
occurred on the same haplotype background. Hence,
we suggest that the disease-causing allele is in tight LD
with SNPs n.7 and n.9 but that the resolution achieved
by the present study should substantially facilitate the
identification of these causal variants. The distribution
of evidence for association at other loci across the in-
terval is of some interest. In addition to SNPs n.7 and
n.9, a further peak—extending from OTF3 to CDSN
and being maximal (in single-marker analysis) for SNP
n.43, located within HCR—is defined by three-marker
analysis. This corresponds to the recently defined as-
sociated HCR haplotype HCR*WW (Asumalahti et al.
2002).
Since we genotyped only three PSORS1 SNPs prox-
imal to SNP n.7, we sought to validate the centromeric
boundary of the critical interval by genotyping three
SNPs within MICA, the closest non-HLA gene. Hap-
lotype analysis demonstrated that the threeMICA SNPs
are in LD with each other and freely associate with
PSORS1 (data not shown). This is in agreement with
the results generated by our survey of LD conservation
in control individuals, showing D′ values !0.2 between
MICA and HLA-C. Altogether, our data support the
occurrence of recombination between these two genes.
Moreover, our data define MICA as a conservative
boundary for the critical region defined by the present
study. This broader interval (MICA lies 150 kb distal
to SNP n.6) contains only one additional functional
gene—namely, the gene encoding the MHC class I an-
tigen HLA-B. Associations between psoriasis and HLA-
B have been repeatedly reported—in particular, HLA-
B57 and HLA-B13 alleles have been implicated in
disease susceptibility (Elder et al. 1994; Balendran et al.
1999). However, both HLA-B57 and HLA-B13 lie on
ancestral haplotypes bearing HLA-Cw*0602 (Elder et
al. 1994; Balendran et al. 1999), suggesting that HLA-
B associations reflect LD with HLA-Cw*0602. Finally,
the results of previous PSORS1 fine-mapping studies of-
fered very little support for the inclusion ofHLA-Bwithin
the critical region (Oka et al. 1999; Nair et al. 2000).
Analysis of extended haplotypes (including all 59
SNPs genotyped in the cohort that we studied) dem-
onstrated that the associated alleles at SNPs n.7 and n.9
are unique to the overtransmitted chromosomes and
define a 10-kb genomic segment (delimited by SNPs n.6
and n.10) as a core risk haplotype. Database analysis
of this restricted region identified a number of repeat
motifs, together with a pseudogene (not expressed) for
the ubiqitin-specific protease–8 gene. All other associ-
ated alleles, including those within HCR and CDSN,
are found to be present on clusters (A–C) that do not
exhibit any evidence of overtransmission. Previous stud-
ies have suggested that disease associations seen with
these genes, both located in the telomeric end of the
MHC class I region, are due to LD with HLA-Cw6
(Jenisch et al. 1999; Chia et al. 2001; O’Brien et al.
2001). To minimize ascertainment bias, we calculated
pairwise LD between SNPs, by studying a control pop-
ulation and using the untransmitted chromosomes from
parents within the trio cohort. D′ scores of 0.80–1.0,
indicating strong LD, were observed for a block from
HLA-C to HCR; however, these values markedly de-
creased between this block and CDSN ( be-′D p 0.15
tween SNPs n.15 and n.58). These data indicate that
recombination has occurred between the regions in the
past and, as such, argue against the hypothesis that as-
sociation between CDSN and psoriasis is due to LD with
HLA-C. Haplotype analysis indicates that the overtrans-
Fi
gu
re
4
P
SO
R
S1
SN
P
ha
pl
ot
yp
es
.
H
ap
lo
ty
pe
s
ar
e
cl
us
te
re
d
on
th
e
ba
si
s
of
th
e
pr
es
en
ce
of
di
se
as
e-
as
so
ci
at
ed
al
le
le
s
(i
nd
ic
at
ed
by
a

or

si
gn
be
fo
re
th
e
lo
cu
s
na
m
e)
at
SN
Ps
n.
7
an
d
n.
9;
at
H
C
R
26
9
(n
.4
3)
(A
su
m
al
ah
ti
et
al
.2
00
0)
,
re
na
m
ed
as
“H
C
R
30
5”
(A
su
m
al
ah
ti
et
al
.2
00
2)
;a
nd
at
C
D
SN
12
43
(n
.5
8)
(A
lle
n
et
al
.1
99
9)
.T
he
la
st
fo
ur
co
lu
m
ns
re
po
rt
ha
pl
ot
yp
e
fr
eq
ue
nc
ie
s
(f
re
q)
,
ob
se
rv
ed
(o
bs
)
ve
rs
us
ex
pe
ct
ed
(e
xp
)
tr
an
sm
is
si
on
s,
an
d
ha
pl
ot
yp
e
st
at
us
(n
eu
tr
al
,
ov
er
tr
an
sm
it
te
d
[o
ve
r]
,
or
un
de
rt
ra
ns
m
it
te
d
[u
nd
er
])
.
562 Am. J. Hum. Genet. 71:554–564, 2002
mitted haplotype in cluster D was probably generated by
recombination between HLA-C and HCR. However,
notably, the clustered haplotype retains the associated
SNP, n.58 (CDSN1243). Finally, 5% of affected indi-
viduals that harbor SNPs n.7 and n.9 do not possess
HLA-Cw6, yet these chromosomes include associated
alleles that are within CDSN. We must assume that this
risk chromosome has been derived after a further re-
combination event between HCR and CDSN.
Cumulatively, these observations provide genetic ev-
idence that a region in close proximity to HLA-C is the
PSORS1 susceptibility locus. Indeed, HLA-Cw*0602
has long been recognized as the marker that is most
significantly associated with psoriasis and as the marker
that confers the highest disease risk (Mallon et al. 1999;
Asumalahti et al. 2000). Case/control studies have re-
ported significant associations, with the Ala-73 and
Asp-9 variant, that define an antigen-binding pocket
unique to HLA-Cw6/Cw7 molecules (Roitberg-Tambur
et al. 1994; Asahina et al. 1996), with HLA-Cw*0602
proving a more discriminatory indicator of disease sus-
ceptibility (Mallon et al. 1997). Data from the present
study have identified haplotypes spanning HLA-C on
at least one undertransmitted haplotype (namely, hap-
lotype 3), leading us to consider that variants within
the coding sequence of the gene encoding HLA-C are
unlikely to be causal in the conferral of disease suscep-
tibility. Rather, the disease allele may lie within a reg-
ulatory region, potentially influencing expression of
HLA-C or other genes in this interval. It is plausible
that structural differences in regulatory elements of
genes within the MHC class I region may have locus-
and tissue-specific effects on expression levels and on
their resultant differential binding affinities for tran-
scription factors. To date, the expression of HLA-C in
normal lesional and nonlesional skin has been poorly
characterized.
Altered activity of HLA-C represents a plausible bio-
logical pathway for psoriasis susceptibility, since it con-
tributes to the process of self-recognition by the immune
system (Cerundolo and Braud 1996). Interestingly, it
has been suggested that psoriasis may be triggered by
direct activation of CD8 and/or natural killer (NK) T
cells, both of which bear receptors for MHC class I
molecules (Bos and De Rie 1999). In particular, it has
been proposed that activating receptors may trigger NK
cells’ cytotoxicity and contribute to the damage of epi-
dermal basal membrane. Conversely, inhibitory recep-
tors, some of which are specific to HLA-C, would pre-
vent the lysis of cells bearing self–MHC class I molecules
(Nickoloff et al. 1999). Clearly, detailed functional anal-
ysis (including expression of HLA-C and response to
key peptides) appear justified in light of high-resolution
genetic studies that have been achieved through a com-
bination of resequencing and SNP-based genotyping.
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